Hormonal
Six months of GLP-1 receptor agonist therapy (exenatide or liraglutide) significantly reduces intrahepatic lipid (liver fat) in obese patients with type 2 diabetes, with the magnitude of reduction correlating strongly with improved glycemic control (HbA1c) rather than total body weight loss.
If you have type 2 diabetes and fatty liver, GLP-1 medications like exenatide or liraglutide can significantly reduce liver fat (by ~42% over 6 months). This benefit is closely tied to better blood sugar control rather than just weight loss. You should discuss these options with your doctor, especially if you are already taking metformin, as they can be added to your current regimen.
Treatment was associated with mean weight loss of 5.0 kg... mean HbA1c reduction of 1.6%... and a 42% relative reduction in IHL... The relative reduction in IHL correlated with that in HbA1c (r = 0.49; p = 0.01) but was not significantly correlated with that in total body weight, VAT or SAT.
Why this rating
Observational cohort study with a small sample size (n=25) and no control group, though using precise imaging (MRS).
Source
Improved Glycaemia Correlates with Liver Fat Reduction in Obese, Type 2 Diabetes, Patients Given Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists
Daniel J. Cuthbertson et al. · PLoS ONE · 2012
DOI 10.1371/journal.pone.0050117
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →